Flowcytometric evidence of platelet activation in patients on aspirin following myocardial infarction.
No Thumbnail Available
Date
2006-03-08
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
BACKGROUND: Following a myocardial infarction, patients are usually started on long term antiplatelet therapy with aspirin in a dose of 80-150 mg/day. However, there are no quick and easy methods to assess the efficacy of the antiplatelet activity of aspirin.
METHODS: We studied 60 consecutive patients (men, < 40 years of age) 8-10 weeks after they had had acute myocardial infarction. These patients were receiving 100 mg aspirin daily orally with or without b-blockers. We measured P-selectin expression and fibrinogen binding by flowcytometry at least 3 times over a period of 2 years in all the patients. We also studied 100 age- and sex-matched controls.
RESULTS: Of the 60 patients, 30 (50%) showed both increased P-selectin and fibrinogen binding by platelets, suggesting platelet activation. Fourteen other patients had increased fibrinogen binding but normal P-selectin expression. Sixteen patients and all the controls had normal results of both tests.
CONCLUSION: Our data show evidence of platelet activation in at least 50% of patients receiving 100 mg of aspirin daily. Flowcytometry for P-selectin expression and fibrinogen binding to platelets can be used to monitor antiplatelet therapy with aspirin following acute myocardial infarction.
Description
Keywords
Citation
Ghosh K, Khare A, Shetty S, Nair S, Kulkarni B, Mohanty D. Flowcytometric evidence of platelet activation in patients on aspirin following myocardial infarction. National Medical Journal of India. 2006 Mar-Apr; 19(2): 73-4